Recombinant Pseudomonas putida Probable efflux pump outer membrane protein ttgC (ttgC)

Shipped with Ice Packs
In Stock

Description

Introduction to Recombinant Pseudomonas putida TtgC

The Pseudomonas putida species is known for its metabolic versatility and resistance mechanisms to various toxic compounds, including antibiotics and organic solvents . One such mechanism involves efflux pumps, which actively expel these compounds from the cell, maintaining cellular integrity . Among these efflux pumps is the TtgABC system, which plays a significant role in the resistance of P. putida to a wide range of antibiotics . TtgC is a component of the TtgABC efflux pump, specifically the outer membrane protein . The TtgABC efflux pump belongs to the resistance-nodulation-division (RND) family of bacterial transporters .

Role of TtgC in Antibiotic Resistance and Solvent Tolerance

The TtgABC efflux pump extrudes a variety of antibiotics, including ampicillin, carbenicillin, tetracycline, nalidixic acid, and chloramphenicol . Mutants lacking TtgB, a component of the TtgABC pump, exhibit decreased resistance to antibiotics, highlighting the importance of this efflux pump in antibiotic resistance . Besides antibiotic resistance, TtgABC also contributes to solvent tolerance in P. putida . P. putida strains can grow in the presence of high concentrations of aromatic hydrocarbons due to the action of TtgABC and other efflux pumps like TtgGHI and TtgDEF .

Regulation of TtgABC Efflux Pump Expression

The expression of the ttgABC operon and its regulatory gene, ttgR, is regulated in response to antibiotics . The expression of ttgABC increases in the presence of hydrophobic antibiotics like chloramphenicol and tetracycline . TtgR, a repressor protein, binds to an operator site that overlaps the ttgABC promoter in the absence of inducers, regulating the expression of the efflux pump .

Functional Redundancy and Substrate Specificity

P. putida DOT-T1E possesses multiple efflux pumps, including TtgABC, TtgDEF, and TtgGHI, which contribute to solvent tolerance . While these pumps share significant sequence identity, they exhibit differences in substrate specificity . TtgABC and TtgGHI extrude both antibiotics and solvents, whereas TtgDEF has a more specific role in solvent efflux .

TtgGHI Efflux Pump and its Regulation

The TtgGHI efflux pump is another RND family transporter that contributes to solvent tolerance and antibiotic resistance in P. putida . The ttgGHI operon is expressed constitutively, and its expression is further induced in the presence of toluene . TtgV, a regulator, represses the expression of the ttgGHI operon, and its activity is modulated by effectors like indole .

Efflux Pumps and Siderophore Secretion

Efflux pumps in P. putida also play a role in the secretion of siderophores, which are essential for iron acquisition . The ParXY efflux system influences the secretion of pyoverdine, a siderophore, under iron-limiting conditions . This highlights the diverse roles of efflux pumps in P. putida, extending beyond antibiotic and solvent resistance to include essential physiological functions.

Product Specs

Form
Lyophilized powder
Note: While we prioritize shipping the format currently in stock, please specify your format preference during order placement for customized preparation.
Lead Time
Delivery times vary depending on the purchasing method and location. Please consult your local distributor for precise delivery estimates.
Note: All proteins are shipped with standard blue ice packs unless dry ice shipping is specifically requested in advance. Additional fees apply for dry ice shipping.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to collect the contents. Reconstitute the protein in sterile, deionized water to a concentration of 0.1-1.0 mg/mL. We recommend adding 5-50% glycerol (final concentration) and aliquoting for long-term storage at -20°C/-80°C. Our standard glycerol concentration is 50% and can serve as a reference.
Shelf Life
Shelf life depends on various factors including storage conditions, buffer composition, temperature, and protein stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized formulations have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquoting is essential for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during the manufacturing process.
The tag type is determined during production. If you require a specific tag, please inform us, and we will prioritize its development.
Synonyms
ttgC; PP_1384; Probable efflux pump outer membrane protein TtgC
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
18-484
Protein Length
Full Length of Mature Protein
Purity
>85% (SDS-PAGE)
Species
Pseudomonas putida (strain ATCC 47054 / DSM 6125 / NCIMB 11950 / KT2440)
Target Names
ttgC
Target Protein Sequence
CSL IPDYQTPEAP VAAQWPQGPA YSPTQSADVA AAEQGWRQFF HDPALQQLIQ TSLVNNRDLR VAALNLDAYR AQYRIQRADL FPAVSATGSG SRQRVPANMS QTGESGITSQ YSATLGVSAY ELDLFGRVRS LTEQALETYL SSEQARRSTQ IALVASVANA YYTWQADQAL FKLTEETLKT YEESYNLTRR SNEVGVASAL DVSQARTAVE GARVKYSQYQ RLVAQDVNSL TVLLGTGIPA DLAKPLELDA DQLAEVPAGL PSDILQRRPD IQEAEHLLKA ANANIGAARA AFFPSISLTA NAGSLSPDMG HLFSGGQGTW LFQPQINLPI FNAGSLKASL DYSKIQKDIN VAKYEKTIQT AFQEVSDGLA ARKTFEEQLQ AQRDLVQANQ DYYRLAERRY RIGIDSNLTF LDAQRNLFSA QQALIGDRLS QLTSEVNLYK ALGGGWYEQT GQANQQASVE TPKG
Uniprot No.

Target Background

Function

Probable outer membrane component of the TtgABC efflux pump with unknown specificity.

Database Links

KEGG: ppu:PP_1384

STRING: 160488.PP_1384

Protein Families
Outer membrane factor (OMF) (TC 1.B.17) family
Subcellular Location
Cell outer membrane; Lipid-anchor.

Q&A

What is the structural and functional role of TtgC in Pseudomonas putida?

TtgC functions as an outer membrane channel component within the TtgABC efflux pump system in Pseudomonas putida. This system belongs to the core genome of P. putida and is especially relevant for the extrusion of antibiotics . As part of the resistance nodulation division (RND) family of efflux pumps, TtgC works in conjunction with other components to form a tripartite structure that enables the bacterium to extrude compounds directly from the cytoplasm to the external environment. By forming the outer membrane channel, TtgC creates a critical passage for antibiotics and other potentially harmful compounds to exit the cell, contributing to the organism's intrinsic resistance mechanisms.

How does the TtgABC system differ from other efflux pumps in P. putida?

P. putida possesses multiple efflux pump systems with distinct substrate specificities and functions:

Efflux PumpGenomic LocationPrimary SubstratesPresent in StrainsKey Functions
TtgABCCore genomeAntibioticsMost P. putida strainsIntrinsic antibiotic resistance
TtgDEFCo-localized with toluene degradation clusterToluene, styreneP. putida DOT-T1E, P. putida GS1Solvent extrusion
TtgGHIVariableAromatic solvents (toluene, styrene)P. putida DOT-T1EKey determinant of solvent tolerance

Unlike TtgDEF and TtgGHI, which are strain-specific and primarily involved in solvent tolerance, TtgABC is part of the core genome and more universally present across P. putida strains . The absence of TtgDEF and TtgGHI in P. putida KT2440 renders this strain sensitive to solvents, highlighting the specialized roles of these different efflux systems.

What mechanisms regulate ttgC gene expression in P. putida?

While the search results don't provide specific details about ttgC regulation in P. putida, we can draw parallels from regulatory mechanisms of RND efflux pumps in related Pseudomonas species. In P. aeruginosa, efflux pump expression can be regulated through dedicated repressor genes, such as mexR for the MexAB-OprM system, and nfxB for the MexCD-OprJ system .

Expression can be induced in response to substrate exposure, as observed with MexXY in P. aeruginosa, which is induced by exposure to various antibiotics including tetracycline . A similar induction mechanism may exist for ttgC in P. putida, particularly when exposed to antibiotics or other substrates of the TtgABC system. Advanced genetic manipulation techniques like CRISPR-interference (CRISPRi) have been developed for P. putida to enable tunable control of gene expression, which can be utilized to study and manipulate ttgC regulation .

How can CRISPR-Cas9 technologies be applied to modify ttgC expression in P. putida?

Several CRISPR-based approaches have been developed specifically for P. putida that can be applied to ttgC studies:

  • I-SceI-mediated recombination assisted by CRISPR-Cas9 counterselection: This genome-engineering approach allows for precise insertions, deletions, or exchanges of genetic parts in the chromosome. For ttgC research, this method could enable the generation of knockout mutants, the introduction of point mutations, or the creation of fusion proteins to study structure-function relationships .

  • CRISPRi toolbox for tunable control: Single-plasmid CRISPR-interference systems in P. putida allow for tunable, tightly controlled gene repression. This system enables either individual or simultaneous suppression of chromosomally-expressed genes. For ttgC, this could be used to achieve partial knockdown to study dose-dependent effects or to analyze the consequences of reduced ttgC expression on antibiotic resistance or solvent tolerance .

  • Base-editing systems: Unconstrained CRISPR-editing via cytidine and adenine base-substitution has been adapted for P. putida. This approach utilizes a novel protospacer adjustment motif (PAM)-relaxed nCas9 variant, making the vast majority of the bacterial genome targetable. For ttgC, this could enable the introduction of specific amino acid changes to study structure-function relationships without the need for complete gene replacement .

  • Self-curing vectors: Induction-dependent, self-curing vectors have been created to enable efficient curing of plasmids after gene editing is complete. This is particularly valuable for ttgC studies where the continued presence of the CRISPR machinery might affect the phenotype being studied .

What experimental approaches can determine TtgC's substrate specificity profile?

Determining the substrate specificity of TtgC requires a combination of genetic and biochemical approaches:

  • Comparative susceptibility testing: Generate isogenic strains with and without functional ttgC to identify compounds that show differential susceptibility. This approach has been used effectively in P. aeruginosa to identify substrates of the MexXY efflux pump by comparing wild-type PAO1 with a mexXY deletion mutant .

  • Inducible expression systems: Develop strains where ttgC expression can be controlled, then measure how varying expression levels affect resistance to different compounds. The expanded CRISPRi toolbox developed for P. putida enables such tunable control .

  • Fluorescent substrate accumulation assays: Use fluorescent compounds that are potential substrates of TtgC and measure their intracellular accumulation in strains with varying levels of ttgC expression. Fluorescent reporter systems developed for P. putida could be adapted for this purpose .

  • Purified protein interaction studies: Express and purify recombinant TtgC to study direct interactions with potential substrates using techniques such as surface plasmon resonance or isothermal titration calorimetry.

How does TtgC contribute to the bioremediation potential of P. putida?

P. putida is known for its ability to degrade aromatic acids and has applications in bioremediation . The TtgABC efflux system, including TtgC, may contribute to this capability in several ways:

  • Enhanced tolerance to toxic compounds: By efficiently extruding toxic aromatic compounds, TtgC may allow P. putida to survive and function in contaminated environments.

  • Substrate export during degradation: During the degradation of aromatic compounds, toxic intermediates may form. TtgC could help export these intermediates, preventing their accumulation to toxic levels inside the cell.

  • Strain optimization: Understanding TtgC function can inform the development of enhanced P. putida strains for bioremediation. For example, strains engineered for improved TtgC expression might show enhanced tolerance to specific environmental contaminants.

  • Integration with biodegradation pathways: TtgC activity could be coordinated with the expression of biodegradation pathways. In P. putida DOT-T1E, the TtgDEF system is genetically co-localized with a toluene degradation cluster, suggesting coordinated regulation .

What are the key considerations when designing experiments to assess TtgC-mediated efflux?

When designing experiments to study TtgC-mediated efflux, researchers should consider:

  • Appropriate control strains:

    • Wild-type P. putida strain

    • ttgC deletion mutant

    • Complemented mutant (ttgC deletion with plasmid-expressed ttgC)

    • Strain with ttgC overexpression

  • Selection of appropriate substrates: Based on known specificity of TtgABC for antibiotics , include various classes of antibiotics in assays. Consider also testing aromatic compounds given P. putida's known interactions with such substrates.

  • Growth conditions: Ensure consistent growth conditions, as efflux pump expression can vary with growth phase and environmental conditions.

  • Gene expression verification: Confirm ttgC expression levels using qRT-PCR or western blotting, especially when using inducible or repressible systems.

  • Substrate concentration range: Test a wide range of substrate concentrations to determine MICs and generate accurate dose-response curves.

  • Time-course experiments: Monitor efflux activity over time to capture both immediate and adaptive responses.

How can adaptive laboratory evolution (ALE) be used to study TtgC function?

Adaptive laboratory evolution represents a powerful approach to study TtgC function and potential:

  • Tolerization Adaptive Laboratory Evolution (TALE): This approach has been successfully used with P. putida to develop strains with enhanced tolerance to compounds like isoprenol . Similar methods could be applied to evolve P. putida strains with enhanced TtgC-mediated efflux capabilities.

  • Experimental design for ALE:

    • Start with multiple independent lineages (e.g., quadruplicate) to identify convergent evolutionary paths

    • Gradually increase selective pressure (substrate concentration)

    • Monitor growth rates to assess adaptation

    • Sequence evolved clones to identify mutations

  • Phenotypic characterization: Compare growth rates of evolved strains in the presence of TtgC substrates. For example, evolved P. putida strains have demonstrated robust growth (up to 0.2 h-1) at concentrations where starting strains could not grow .

  • Genomic analysis: Whole genome resequencing of independently evolved lineages can identify convergent mutations that might affect ttgC expression or function .

  • Reverse engineering: Introduce identified mutations into the parental strain to confirm their role in enhanced TtgC function.

What are the recommended methods for recombinant expression and purification of TtgC?

For successful recombinant expression and purification of TtgC, consider the following methodological approaches:

  • Expression system selection:

    • Homologous expression in P. putida: Maintains native folding environment but may have lower yields

    • Heterologous expression in E. coli: Higher yields but may face challenges with proper folding

    • Cell-free expression systems: For potentially toxic proteins

  • Expression vector design:

    • Include affinity tags (His6, FLAG, etc.) to facilitate purification

    • Consider fusion partners to enhance solubility (MBP, SUMO, etc.)

    • Use inducible promoters to control expression timing and level

  • Membrane protein-specific considerations:

    • Include detergents in lysis and purification buffers to solubilize membrane proteins

    • Test multiple detergents (DDM, LDAO, etc.) for optimal stability

    • Consider using nanodiscs or amphipols for stabilization in a membrane-like environment

  • Purification strategy:

    • Initial capture using affinity chromatography

    • Secondary purification using ion exchange or size exclusion chromatography

    • Quality assessment by SDS-PAGE, western blotting, and activity assays

How can CRISPR tools be optimized for studying ttgC in P. putida?

Based on the developed CRISPR tools for P. putida, researchers can optimize their approach to studying ttgC:

  • Guide RNA design for ttgC targeting:

    • Select target sites with minimal off-target effects

    • Consider using PAM-relaxed nCas9 variants to increase targeting options within the ttgC sequence

    • Design multiple gRNAs to target different regions of ttgC for comprehensive analysis

  • Vector system selection:

    • For gene knockouts: I-SceI-mediated recombination assisted by CRISPR-Cas9 counterselection

    • For expression modulation: Single-plasmid CRISPR-interference (CRISPRi) system

    • For precise mutations: Cytidine and adenine base-substitution systems

  • Validation strategies:

    • PCR and sequencing to confirm genetic modifications

    • RT-qPCR to verify changes in ttgC expression levels

    • Phenotypic assays to confirm functional consequences

  • Plasmid curing:

    • Utilize the induction-dependent, self-curing vectors to remove CRISPR components after editing

    • Confirm plasmid loss by antibiotic sensitivity testing

How should researchers interpret TtgC expression data in relation to antibiotic resistance?

When analyzing the relationship between TtgC expression and antibiotic resistance:

  • Correlation vs. causation:

    • Establish causality through complementation studies and controlled expression experiments

    • Consider other factors that might influence resistance beyond TtgC expression

  • Quantitative analysis approaches:

    • Calculate fold changes in MIC values relative to control strains

    • Generate dose-response curves and calculate EC50 values

    • Use multivariate analysis to assess contributions of multiple factors

  • Interpreting contradictory results:

    • Consider strain background differences

    • Evaluate experimental conditions that might affect results

    • Assess potential compensatory mechanisms (e.g., upregulation of alternative efflux systems)

  • Comparative analysis with other species:

    • Draw parallels with well-characterized systems like MexXY in P. aeruginosa

    • Consider evolutionary conservation and divergence of efflux mechanisms

What statistical methods are most appropriate for analyzing TtgC-substrate interaction data?

For rigorous analysis of TtgC-substrate interaction data:

  • Growth inhibition assays:

    • Analysis of variance (ANOVA) to compare MICs across multiple strains

    • Nonlinear regression for dose-response curves

    • Calculation of IC50 values and comparison using t-tests or ANOVA

  • Gene expression studies:

    • qPCR data analysis using the ΔΔCt method

    • Multiple comparison corrections for analyzing expression of multiple genes

    • Time-course expression data may require time series analysis methods

  • Adaptive evolution experiments:

    • Survival analysis techniques for comparing adaptation rates

    • Statistical methods for identifying convergent mutations

    • Multivariate analysis to correlate genomic changes with phenotypic outcomes

  • Structural and binding studies:

    • Curve fitting for binding isotherms

    • Statistical comparison of binding parameters across different substrates

    • Multiple testing correction when screening numerous potential substrates

How might TtgC engineering contribute to enhanced bioremediation applications?

The strategic engineering of TtgC could significantly advance P. putida's bioremediation capabilities:

  • Substrate specificity modification:

    • Engineer TtgC to enhance specificity for environmental pollutants

    • Modify the channel diameter or surface properties to accommodate larger pollutant molecules

    • Create variants with altered substrate preferences through directed evolution

  • Expression optimization:

    • Develop regulatory systems that induce ttgC expression in response to specific pollutants

    • Create constitutive high-expression variants for continuous bioremediation applications

    • Optimize promoter strength to balance efflux capability with metabolic burden

  • Integration with metabolic engineering:

    • Coordinate TtgC-mediated efflux with pollutant degradation pathways

    • Balance influx, degradation, and efflux to optimize bioremediation efficiency

    • Consider whole-cell biocatalyst approaches where TtgC contributes to cell viability

  • Field application considerations:

    • Stability of engineered TtgC variants in environmental conditions

    • Persistence of engineered P. putida strains in contaminated sites

    • Regulatory considerations for releasing engineered strains

What are the most promising approaches for resolving TtgC's three-dimensional structure?

Understanding TtgC's structure is crucial for rational engineering efforts:

  • X-ray crystallography challenges and solutions:

    • Membrane protein crystallization using lipidic cubic phase methods

    • Co-crystallization with antibody fragments to stabilize flexible regions

    • Use of detergent screening to identify conditions that maintain native structure

  • Cryo-electron microscopy (cryo-EM):

    • Single-particle analysis for high-resolution structure determination

    • Analysis of TtgC within the context of the complete TtgABC efflux system

    • Time-resolved cryo-EM to capture different conformational states

  • Computational approaches:

    • Homology modeling based on related proteins with known structures

    • Molecular dynamics simulations to predict flexible regions and conformational changes

    • Integration of experimental data with computational models for hybrid approaches

  • Structural validation:

    • Functional testing of structure-based predictions

    • Site-directed mutagenesis to confirm key residues identified in structural models

    • Cross-linking studies to validate protein-protein interaction interfaces

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.